334 related articles for article (PubMed ID: 28087782)
1. Mutation Supply and Relative Fitness Shape the Genotypes of Ciprofloxacin-Resistant Escherichia coli.
Huseby DL; Pietsch F; Brandis G; Garoff L; Tegehall A; Hughes D
Mol Biol Evol; 2017 May; 34(5):1029-1039. PubMed ID: 28087782
[TBL] [Abstract][Full Text] [Related]
2. Molecular epidemiology and mutations at gyrA and parC genes of ciprofloxacin-resistant Escherichia coli isolates from a Taiwan medical center.
Chen JY; Siu LK; Chen YH; Lu PL; Ho M; Peng CF
Microb Drug Resist; 2001; 7(1):47-53. PubMed ID: 11310803
[TBL] [Abstract][Full Text] [Related]
3. Emergence of a new mutation and its accumulation in the topoisomerase IV gene confers high levels of resistance to fluoroquinolones in Escherichia coli isolates.
Moon DC; Seol SY; Gurung M; Jin JS; Choi CH; Kim J; Lee YC; Cho DT; Lee JC
Int J Antimicrob Agents; 2010 Jan; 35(1):76-9. PubMed ID: 19781915
[TBL] [Abstract][Full Text] [Related]
4. 'Supermutators' found amongst highly levofloxacin-resistant E. coli isolates: a rapid protocol for the detection of mutation sites.
Zayed AA; Essam TM; Hashem AG; El-Tayeb OM
Emerg Microbes Infect; 2015 Jan; 4(1):e4. PubMed ID: 26038761
[TBL] [Abstract][Full Text] [Related]
5. Does mutation in gyrA and/or parC or efflux pump expression play the main role in fluoroquinolone resistance in Escherichia coli urinary tract infections?: A statistical analysis study.
Shigemura K; Tanaka K; Yamamichi F; Shirakawa T; Miyake H; Fujisawa M
Int J Antimicrob Agents; 2012 Dec; 40(6):516-20. PubMed ID: 23068598
[TBL] [Abstract][Full Text] [Related]
6. Fitness cost constrains the spectrum of marR mutations in ciprofloxacin-resistant Escherichia coli.
Praski Alzrigat L; Huseby DL; Brandis G; Hughes D
J Antimicrob Chemother; 2017 Nov; 72(11):3016-3024. PubMed ID: 28962020
[TBL] [Abstract][Full Text] [Related]
7. Bactericidal activity and target preference of a piperazinyl-cross-linked ciprofloxacin dimer with Staphylococcus aureus and Escherichia coli.
Zhao X; Quinn B; Kerns R; Drlica K
J Antimicrob Chemother; 2006 Dec; 58(6):1283-6. PubMed ID: 17003060
[TBL] [Abstract][Full Text] [Related]
8. Geographic distribution of fluoroquinolone-resistant Escherichia coli strains in Asia.
Uchida Y; Mochimaru T; Morokuma Y; Kiyosuke M; Fujise M; Eto F; Harada Y; Kadowaki M; Shimono N; Kang D
Int J Antimicrob Agents; 2010 Apr; 35(4):387-91. PubMed ID: 20138480
[TBL] [Abstract][Full Text] [Related]
9. Urinary Tract Physiological Conditions Promote Ciprofloxacin Resistance in Low-Level-Quinolone-Resistant Escherichia coli.
Martín-Gutiérrez G; Rodríguez-Beltrán J; Rodríguez-Martínez JM; Costas C; Aznar J; Pascual Á; Blázquez J
Antimicrob Agents Chemother; 2016 Jul; 60(7):4252-8. PubMed ID: 27139482
[TBL] [Abstract][Full Text] [Related]
10. Population Bottlenecks Strongly Influence the Evolutionary Trajectory to Fluoroquinolone Resistance in Escherichia coli.
Garoff L; Pietsch F; Huseby DL; Lilja T; Brandis G; Hughes D
Mol Biol Evol; 2020 Jun; 37(6):1637-1646. PubMed ID: 32031639
[TBL] [Abstract][Full Text] [Related]
11. Shared and Unique Evolutionary Trajectories to Ciprofloxacin Resistance in Gram-Negative Bacterial Pathogens.
Zlamal JE; Leyn SA; Iyer M; Elane ML; Wong NA; Wamsley JW; Vercruysse M; Garcia-Alcalde F; Osterman AL
mBio; 2021 Jun; 12(3):e0098721. PubMed ID: 34154405
[TBL] [Abstract][Full Text] [Related]
12. De Novo Characterization of Genes That Contribute to High-Level Ciprofloxacin Resistance in Escherichia coli.
Tran T; Ran Q; Ostrer L; Khodursky A
Antimicrob Agents Chemother; 2016 Oct; 60(10):6353-5. PubMed ID: 27431218
[TBL] [Abstract][Full Text] [Related]
13. Contribution of mutations in DNA gyrase and topoisomerase IV genes to ciprofloxacin resistance in Escherichia coli clinical isolates.
Bansal S; Tandon V
Int J Antimicrob Agents; 2011 Mar; 37(3):253-5. PubMed ID: 21236644
[TBL] [Abstract][Full Text] [Related]
14. Selective concentration for ciprofloxacin resistance in Escherichia coli grown in complex aquatic bacterial biofilms.
Kraupner N; Ebmeyer S; Bengtsson-Palme J; Fick J; Kristiansson E; Flach CF; Larsson DGJ
Environ Int; 2018 Jul; 116():255-268. PubMed ID: 29704804
[TBL] [Abstract][Full Text] [Related]
15. Antibiotic resistance begets more resistance: chromosomal resistance mutations mitigate fitness costs conferred by multi-resistant clinical plasmids.
Nair RR; Andersson DI; Warsi OM
Microbiol Spectr; 2024 May; 12(5):e0420623. PubMed ID: 38534122
[TBL] [Abstract][Full Text] [Related]
16. Mutant prevention concentration of ciprofloxacin and enrofloxacin against Escherichia coli, Salmonella Typhimurium and Pseudomonas aeruginosa.
Pasquali F; Manfreda G
Vet Microbiol; 2007 Jan; 119(2-4):304-10. PubMed ID: 16987619
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of antibiotic resistance in Escherichia coli isolates obtained from healthy children in Spain.
Domínguez E; Zarazaga M; Sáenz Y; Briñas L; Torres C
Microb Drug Resist; 2002; 8(4):321-7. PubMed ID: 12523629
[TBL] [Abstract][Full Text] [Related]
18. Impact of plasmid-borne oqxAB on the development of fluoroquinolone resistance and bacterial fitness in Escherichia coli.
Wang J; Guo ZW; Zhi CP; Yang T; Zhao JJ; Chen XJ; Zeng L; Lv LC; Zeng ZL; Liu JH
J Antimicrob Chemother; 2017 May; 72(5):1293-1302. PubMed ID: 28160469
[TBL] [Abstract][Full Text] [Related]
19. Fluoroquinolone resistance mechanisms in urinary tract pathogenic Escherichia coli isolated during rapidly increasing fluoroquinolone consumption in a low-use country.
Christiansen N; Nielsen L; Jakobsen L; Stegger M; Hansen LH; Frimodt-Møller N
Microb Drug Resist; 2011 Sep; 17(3):395-406. PubMed ID: 21668371
[TBL] [Abstract][Full Text] [Related]
20. Upregulation of AcrEF in Quinolone Resistance Development in Escherichia coli When AcrAB-TolC Function Is Impaired.
Zhang CZ; Chang MX; Yang L; Liu YY; Chen PX; Jiang HX
Microb Drug Resist; 2018; 24(1):18-23. PubMed ID: 28520511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
